Disclosures for "Adjunctive Cenobamate for the Treatment of Primary Generalized Tonic-Clonic Seizures in Adults and Adolescents: Design of a Phase 3 Study With Open-Label Extension"
-
Dr. Nisman has received personal compensation for serving as an employee of SK Life Science, Inc.. Dr. Nisman has a non-compensated relationship as a Senior Director, Medical Affairs with SK Life Science, Inc. that is relevant to AAN interests or activities.
-
Dr. Misra has received personal compensation for serving as an employee of Neurelis, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Misra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RubiconMD. Dr. Misra has received intellectual property interests from a discovery or technology relating to health care.
-
Louis Ferrari has received personal compensation for serving as an employee of SK Life science.